NCT04928287View on ClinicalTrials.gov

Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 28, 2021

Primary Completion Date

February 6, 2023

Study Completion Date

February 6, 2023

Conditions
Parkinson Disease
Interventions
BIOLOGICAL

HB-adMSCs

HB-adMSCs will be administered intravenously to study participants who qualify.

OTHER

Placebo

Placebo will be administered intravenously to study participants who qualify.

Trial Locations (1)

77478

Hope Biosciences Stem Cell Research Foundation, Sugar Land

All Listed Sponsors
lead

Hope Biosciences Research Foundation

INDUSTRY